Objective: To compare the efficacy of methotrexate versus acitretin in the treatment of chronic plaque psoriasis Method: Randomized Controlled Trial conducted in Dermatology Department, Services Hospital Lahore, on 60 patients after informed consent,divided into two groups. Group A was given methotrexate 0.3-0.5mg/kg orally and Group B was given acitretin 0.4mg/kg orally. Efficacy was ascertained by reduction in PASI score, calculated at baseline and at 12 weeks Results : Patients of Group A achieved a reduction in PASI score from baseline 13.13±2.047 to 6.20±2.024 (efficacy76.7%) while in Group B, PASI score dropped from 13.53±2.047 to 7.00±1.857 (efficacy 56.7%) . Adverse effects for both groups were minimal. Conclusion: Both methotrexate and acitretin are highly effective drugs in treating chronic plaque psoriasis. However, methotrexate showed greater efficacy and faster reduction in PASI as compared to acitretin.